Here is an idea that I am going to pursue this coming week - feel free to join me.
Let me give you the profile of the company.
Name: ImmuCell Corporation
Sector, Industry, Country: Healthcare | Biotechnology | USA
Plain English Overview:
They create health products, in the form of pills & vaccines, to make for healthier cattle.
The goal is to reduce the use of antibiotics in the American food chain.
________________________________________________________________________________________________
I've divided the fundamentals into 6 parts. These six parts are based on research, and I think they are the most important criteria to consider when thinking about investing in a company, especially a small one.
Fundamentals
VALUE
-- P/B: 1.3
DILUTION
-- 7M shares
QUALITY
-- Debt/Equity < 0.3
-- Long-term debt/equity < 0.3
CASH
-- P/C: 5.3
OWNERSHIP
-- Insider: 28%
-- Institutional: 20%
GROWTH
--Quarterly revenue growth: 11%
________________________________________________________________________________________________
Now let's talk about technicals, briefly.
The stock is at the bottom of its range and is putting in a double bottom with a breakout ('W').
All in all, the stock seems like a pretty good idea to pursue - as long as you position-size (i.e don't risk more than 5%), I think it's not a bad idea. 📈
Let me give you the profile of the company.
Name: ImmuCell Corporation
Sector, Industry, Country: Healthcare | Biotechnology | USA
Plain English Overview:
They create health products, in the form of pills & vaccines, to make for healthier cattle.
The goal is to reduce the use of antibiotics in the American food chain.
________________________________________________________________________________________________
I've divided the fundamentals into 6 parts. These six parts are based on research, and I think they are the most important criteria to consider when thinking about investing in a company, especially a small one.
Fundamentals
VALUE
-- P/B: 1.3
DILUTION
-- 7M shares
QUALITY
-- Debt/Equity < 0.3
-- Long-term debt/equity < 0.3
CASH
-- P/C: 5.3
OWNERSHIP
-- Insider: 28%
-- Institutional: 20%
GROWTH
--Quarterly revenue growth: 11%
________________________________________________________________________________________________
Now let's talk about technicals, briefly.
The stock is at the bottom of its range and is putting in a double bottom with a breakout ('W').
All in all, the stock seems like a pretty good idea to pursue - as long as you position-size (i.e don't risk more than 5%), I think it's not a bad idea. 📈
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.